Stay updated on CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A banner announces NIH’s website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence,” with updates and FAQs available.
    Difference
    0.9%
    Check dated 2026-10-24T16:27:07.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T16:12:57.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1, while the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-10T16:15:17.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the record history and the previous revision v3.6.6 was removed from the list.
    Difference
    0.1%
    Check dated 2026-09-19T19:04:03.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The study record history shows a new revision (v3.6.6) replacing the previous (v3.6.5). This indicates an update to the page's documentation.
    Difference
    0.1%
    Check dated 2026-08-29T18:41:44.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.5, appears in the study history, replacing the previous v3.6.4. This reflects an update to the page metadata on the ClinicalTrials.gov record.
    Difference
    0.1%
    Check dated 2026-08-08T09:36:12.000Z thumbnail image

Stay in the know with updates to CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.